Rezolute, Inc. Common Stock (NV) (RZLT)
NASDAQ · Manufacturing · Pharmaceutical preparations
RZLT price, last 12 months
Key stats
- Previous close
- $4.25
- Open
- $4.25
- Day range
- $3.96 – $4.42
- 52-week range
- $1.07 – $11.17
- Volume
- 2.4M
- Avg volume (20 days)
- 1.8M
- Market cap
- $353.5M
Performance
Technicals and fundamentals
About Rezolute, Inc. Common Stock (NV)
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $353.5M